Cancer News and Research

Latest Cancer News and Research

Microscopic worms in space

A space flight by millions of microscopic worms could help us overcome the numerous threats posed to human health by space travel. The Caenorhabditis elegans (C. elegans) have also given experts an insight into how to block muscle degradation in the sick and elderly.

2 Jun 2011

People with individual health coverage have highest cancer costs

One of every seven cancer patients spends more than 20 percent of his income on health care and insurance, according to a new study from federal researchers.

2 Jun 2011

AVEO’s ficlatuzumab-gefitinib Phase 1b/2 trial data against NSCLC to be presented at ASCO 2011

AVEO Pharmaceuticals, Inc. today announced results from the Phase 1b portion of its Phase 1b/2 clinical study of ficlatuzumab in combination with gefitinib in Asian subjects with non-small cell lung cancer.

2 Jun 2011

WHO warns of tobacco dangers on World No Tobacco Day

"Tobacco will kill nearly six million people this year, including 600,000 non-smokers, because governments are not doing enough to persuade people to quit or protect others from second-hand smoke, the World Health Organization (WHO) said on Tuesday," which was observed as World No Tobacco Day, Reuters/Toronto Sun reports.

2 Jun 2011

Loyola to offer free lecture on anterior-approach hip replacement surgery

On Tuesday, June 14th, Dr. Michael Stover of Loyola University Health System will give a free lecture in Burr Ridge on the muscle-preserving anterior-approach hip replacement surgery.

2 Jun 2011

Symphogen's rozrolimupab Phase 2 data to be presented at European Hematology Association meeting

Symphogen announced today that Phase 2 data will be presented from an open-label, multi-center clinical trial evaluating the safety and tolerability of rozrolimupab in adult, RhD positive, non-splenectomized patients with Immune thrombocytopenia (ITP) at the 16th Congress of the European Hematology Association meeting in London, UK on June 10 from 5:45 to 7:00 PM.

2 Jun 2011

WHO/IARC say mobile phone use may increase risk of certain brain cancers

Mobile phone use "may increase the risk of certain types of brain cancer in humans," therefore "consumers should consider ways of reducing their exposure," a WHO/International Agency for Research on Cancer (IARC) working group concluded on Tuesday, Reuters reports.

2 Jun 2011

Cell phone use poses no cancer risk, says JunkScience publisher

Today's media hoopla about the World Health Organization classifying cell phone use as "possibly carcinogenic" is much ado about nothing. The studies the WHO relies on are weak association studies that have zero reliability.

2 Jun 2011

Repligen announces completion of RG1068 pre-New Drug Application meeting with U.S. FDA

Repligen Corporation today announced that the Company has concluded a pre-New Drug Application (NDA) meeting with the U.S. Food and Drug Administration related to its lead product candidate, RG1068 for improvement of magnetic resonance imaging of the pancreas.

2 Jun 2011

Positive results from Nuvilex European Phase II trial against pancreatic cancer

Nuvilex, Inc. announces the favorable results of a completed Phase II clinical trial carried out in Europe against pancreatic cancer. The treatment technology used in this trial was recently acquired by Nuvilex.

2 Jun 2011

Patients with advanced NSCLC can benefit from less toxic combination of erlotinib, bevacizumab

The standard treatment for patients with advanced non-small cell lung cancer is a combination of two old-fashioned cytotoxic chemotherapy drugs. The combination, however, comes with substantial toxicity.

2 Jun 2011

Investigators to examine how Ephb2 gene causes ependymoma in children

Armed with new grant support, investigators at Nationwide Children's Hospital plan to examine how a common gene of the nervous system leads to the development of a devastating brain tumor, ependymoma.

2 Jun 2011

Five organizations receive IASLC travel awards to attend 14th World Conference on Lung Cancer

Five advocacy organizations from India, Australia and the United States have been granted travel awards by the International Association for the Study of Lung Cancer (IASLC) to send representatives to the 14th World Conference on Lung Cancer, July 3-7 in Amsterdam.

2 Jun 2011

Lymphocyte count serves as simple and effective prognostic indicator in renal cell carcinoma

Each year, kidney cancer is diagnosed in nearly 60,000 people in the U.S. Many of these patients undergo surgery to remove the affected kidney, but this procedure can be risky for the elderly and those who have other health problems. Unfortunately, the prognosis of kidney cancer patients often cannot be determined until tumor samples are surgically removed and evaluated.

2 Jun 2011

Researchers discover overactive genes that drive triple-negative breast cancer cells

Scientists at Dana-Farber Cancer Institute have identified an overactive network of growth-spurring genes that drive stem-like breast cancer cells enriched in triple-negative breast tumors, a typically aggressive cancer that is highly resistant to current therapies.

2 Jun 2011

UV-screening sunglasses, contact lenses can protect eyes from aging and disease

Most of us know that UV-blocking sunscreen protects the skin from aging and disease but we don't realize that UV-screening sunglasses and contact lenses can protect eyes from aging and disease, according to a national American Optometric Association survey.

2 Jun 2011

PCF funds 14 new Creativity Awards for advanced prostate cancer research

The Prostate Cancer Foundation today announced that it has funded 14 new Creativity Awards for advanced prostate cancer research. These two-year awards are designed to support innovative research ideas that have the potential to achieve breakthroughs for improved prostate cancer diagnosis and treatment.

2 Jun 2011

Adipose-derived stem cell procedure restores skull defects after brain surgery

Stem cells derived from abdominal fat—used along with a synthetic bone grafting material—are a potentially valuable new approach to repairing skull defects after brain surgery, according to a study in the June issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.

2 Jun 2011

Niiki Pharma to present NKP-1339 Phase I trial against metastatic cancer at ASCO 2011

Niiki Pharma announced today that it will present interim data from the ongoing Phase I clinical study for its lead product, NKP-1339, at the 2011 American Society for Clinical Oncology meeting in Chicago, IL.

2 Jun 2011

XTL receives FDA Orphan-drug designation for rHuEPO drug to treat Multiple Myeloma

On May 29, 2011 XTL has announced that its rHuEPO drug which is currently in preparations for phase 2 clinical trial, has been granted an Orphan-drug designation by the US Food and Drug Administration (FDA) for treatment of Multiple Myeloma blood cancer.

2 Jun 2011

Cancer News and Research

Latest Cancer News and Research

Microscopic worms in space

People with individual health coverage have highest cancer costs

AVEO’s ficlatuzumab-gefitinib Phase 1b/2 trial data against NSCLC to be presented at ASCO 2011

WHO warns of tobacco dangers on World No Tobacco Day

Loyola to offer free lecture on anterior-approach hip replacement surgery

Symphogen's rozrolimupab Phase 2 data to be presented at European Hematology Association meeting

WHO/IARC say mobile phone use may increase risk of certain brain cancers

Cell phone use poses no cancer risk, says JunkScience publisher

Repligen announces completion of RG1068 pre-New Drug Application meeting with U.S. FDA

Positive results from Nuvilex European Phase II trial against pancreatic cancer

Patients with advanced NSCLC can benefit from less toxic combination of erlotinib, bevacizumab

Investigators to examine how Ephb2 gene causes ependymoma in children

Five organizations receive IASLC travel awards to attend 14th World Conference on Lung Cancer

Lymphocyte count serves as simple and effective prognostic indicator in renal cell carcinoma

Researchers discover overactive genes that drive triple-negative breast cancer cells

UV-screening sunglasses, contact lenses can protect eyes from aging and disease

PCF funds 14 new Creativity Awards for advanced prostate cancer research

Adipose-derived stem cell procedure restores skull defects after brain surgery

Niiki Pharma to present NKP-1339 Phase I trial against metastatic cancer at ASCO 2011

XTL receives FDA Orphan-drug designation for rHuEPO drug to treat Multiple Myeloma

Understanding the DNA Damage Response in Innate Immunity eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in